Please assess the completion status of the following clinical trial:

Trial Title: Frequency of Reduced Leaflet Motion After Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Replacement.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~Scheduled for SAVR or TAVR~* Age \> 18 years~* Able and willing to give informed consent~* Able and willing to return for follow up~Exclusion Criteria:~* Contraindications to warfarin, Plavix or aspirin~* Pre-existing medical indication for warfarin, Plavix or aspirin~* History of previous cardiac surgery~* History of previous coronary artery stenting~* Requirement for concomitant coronary artery bypass grafting or mitral valve surgery or surgical treatment of an ascending aortic aneurysm~* Contraindications to contrast-enhanced MDCT including anaphylactic iodine allergy, uncontrolled atrial fibrillation, renal dysfunction (GFR \< 60 ml/min).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- SAVR Warfarin Arm (Type: EXPERIMENTAL): Warfarin arm-(target INR of 2-3)
- TAVR Warfarin and Clopidogrel Arm (Type: EXPERIMENTAL): Warfarin (target INR of 2-3) and Clopidogrel (75mg/day) arm
- SAVR Aspirin Arm (Type: EXPERIMENTAL): Aspirin arm (81mg/day)
- TAVR Aspirin and Clopidogrel Arm (Type: EXPERIMENTAL): Aspirin (81mg/day) and Clopidogrel (75mg/day) arm

Based on this trial design, predict the completion outcome and termination type (if applicable).